Cargando…
New COVID-19 Vaccines, Its Cost and Shelf Life: A Cost Effectiveness Analysis
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
IMSS. Published by Elsevier Inc.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7755566/ https://www.ncbi.nlm.nih.gov/pubmed/33485639 http://dx.doi.org/10.1016/j.arcmed.2020.12.008 |
| _version_ | 1783626374258360320 |
|---|---|
| author | Sookaromdee, Pathum Wiwanitkit, Viroj |
| author_facet | Sookaromdee, Pathum Wiwanitkit, Viroj |
| author_sort | Sookaromdee, Pathum |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7755566 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | IMSS. Published by Elsevier Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-77555662020-12-23 New COVID-19 Vaccines, Its Cost and Shelf Life: A Cost Effectiveness Analysis Sookaromdee, Pathum Wiwanitkit, Viroj Arch Med Res Letter to the Editor IMSS. Published by Elsevier Inc. 2021-05 2020-12-23 /pmc/articles/PMC7755566/ /pubmed/33485639 http://dx.doi.org/10.1016/j.arcmed.2020.12.008 Text en © 2020 IMSS. Published by Elsevier Inc. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Letter to the Editor Sookaromdee, Pathum Wiwanitkit, Viroj New COVID-19 Vaccines, Its Cost and Shelf Life: A Cost Effectiveness Analysis |
| title | New COVID-19 Vaccines, Its Cost and Shelf Life: A Cost Effectiveness Analysis |
| title_full | New COVID-19 Vaccines, Its Cost and Shelf Life: A Cost Effectiveness Analysis |
| title_fullStr | New COVID-19 Vaccines, Its Cost and Shelf Life: A Cost Effectiveness Analysis |
| title_full_unstemmed | New COVID-19 Vaccines, Its Cost and Shelf Life: A Cost Effectiveness Analysis |
| title_short | New COVID-19 Vaccines, Its Cost and Shelf Life: A Cost Effectiveness Analysis |
| title_sort | new covid-19 vaccines, its cost and shelf life: a cost effectiveness analysis |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7755566/ https://www.ncbi.nlm.nih.gov/pubmed/33485639 http://dx.doi.org/10.1016/j.arcmed.2020.12.008 |
| work_keys_str_mv | AT sookaromdeepathum newcovid19vaccinesitscostandshelflifeacosteffectivenessanalysis AT wiwanitkitviroj newcovid19vaccinesitscostandshelflifeacosteffectivenessanalysis |